Share Price & News
How has Consulting & Investment Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: Insufficient data to determine CICO's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine CICO's volatility change over the past year.
7 Day Return
1 Year Return
Return vs Industry: CICO underperformed the JO Healthcare industry which returned 4.9% over the past year.
Return vs Market: CICO underperformed the JO Market which returned 36.5% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Consulting & Investment Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Consulting & Investment Group undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate CICO's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate CICO's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: CICO is unprofitable, so we can't compare its PE Ratio to the Asian Healthcare industry average.
PE vs Market: CICO is unprofitable, so we can't compare its PE Ratio to the JO market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate CICO's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: CICO is good value based on its PB Ratio (1.3x) compared to the XA Healthcare industry average (2.3x).
How is Consulting & Investment Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Consulting & Investment Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Consulting & Investment Group performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CICO is currently unprofitable.
Growing Profit Margin: CICO is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: CICO is unprofitable, but has reduced losses over the past 5 years at a rate of 3.2% per year.
Accelerating Growth: Unable to compare CICO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CICO is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (34.1%).
Return on Equity
High ROE: CICO has a negative Return on Equity (-1.55%), as it is currently unprofitable.
How is Consulting & Investment Group's financial position?
Financial Position Analysis
Short Term Liabilities: CICO's short term assets (JOD7.0M) exceed its short term liabilities (JOD6.8M).
Long Term Liabilities: CICO's short term assets (JOD7.0M) exceed its long term liabilities (JOD4.9M).
Debt to Equity History and Analysis
Debt Level: CICO's debt to equity ratio (0%) is considered satisfactory.
Reducing Debt: CICO's debt to equity ratio has reduced from 4.9% to 0% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if CICO has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if CICO has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is Consulting & Investment Group current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate CICO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CICO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if CICO's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CICO's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of CICO's dividend in 3 years as they are not forecast to pay a notable one for the JO market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Consulting & Investment Group has no CEO, or we have no data on them.
Experienced Management: CICO's management team is seasoned and experienced (13.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
The Consulting & Investment Co. Group. Ltd.'s company bio, employee growth, exchange listings and data sources
- Name: The Consulting & Investment Co. Group. Ltd.
- Ticker: CICO
- Exchange: ASE
- Founded: 1995
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: د.أ25.600m
- Shares outstanding: 20.00m
- Website: https://www.istisharihospital.com
- The Consulting & Investment Co. Group. Ltd.
- Wadi Saqra
- PO Box 840431
The Consulting & Investment Co. Group. Ltd. provides medical care services in Jordan.It also sells medicines. The company was founded in 1995 and is based in Amman, Jordan.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/17 11:32|
|End of Day Share Price||2021/09/16 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.